Reply to K. Dunleavy et al Journal Article
| Authors: | Chadburn, A.; Noy, A.; Lee, J. Y.; Hyjek, E.; Banham, A. H.; Sparano, J. A.; Bhatia, K.; Cesarman, E. |
| Article Title: | Reply to K. Dunleavy et al |
| Keywords: | immunohistochemistry; signal transduction; cancer survival; unclassified drug; single nucleotide polymorphism; prednisone; doxorubicin; cancer combination chemotherapy; rituximab; human immunodeficiency virus infection; follow up; letter; cell proliferation; reproducibility; phenotype; protein bcl 2; protein; cyclophosphamide; vincristine; immunoglobulin enhancer binding protein; retrospective study; protein p53; germinal center; epigenetics; myc protein; acquired immune deficiency syndrome; protein bcl 6; large cell lymphoma; kaposi sarcoma; methylated dna protein cysteine methyltransferase; tissue microarray; comparative genomic hybridization; epstein barr virus; multidrug resistance; immunocompetence; human herpesvirus 8; interferon regulatory factor 4; histogenesis; glycoprotein p; a20 protein |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 28 |
| Issue: | 16 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2010-06-01 |
| Start Page: | e261 |
| End Page: | e262 |
| Language: | English |
| DOI: | 10.1200/jco.2010.28.0305 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Export Date: 20 April 2011" - "CODEN: JCOND" - "Source: Scopus" |
